无锡途深智合人工智能科技有限公司及子公司上海途深生物科技有限责任公司（以下简称「途深智合」）近日宣布，成功完成数百万元天使轮融资。本次融资的投资方为诚美资本，资金将主要用于实验室建设与团队扩充。成立于2023年的途深智合，是一家专注于人工智能（AI）蛋白质设计和制造的生物科技企业，致力于为合成生物领域开发新产品，并提供全面的解决方案。
英文标题：”TuShenCheng AI Tech Secures Angel Round Investment for Protein Design Innovations”
英文关键词：Biotechnology, AI for protein design, Funding
英文新闻内容：
TuShenCheng AI Tech, a biotechnology company specializing in artificial intelligence (AI) driven protein design and manufacturing, has announced the completion of a multi-million-dollar angel round investment. The funding, provided by ChenMing Capital, will be used to establish a state-of-the-art laboratory and build a skilled team. Established in 2023, TuShenCheng AI Tech is dedicated to developing new products for the synthetic biology sector and offering comprehensive solutions.
【来源】https://36kr.com/p/2686282258132355
Views: 1